Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Fructose-1,6-bisphosphate aldolase (EC 126.96.36.199) is a tetrameric glycolytic enzyme that catalyzes the reversible conversion of fructose-1,6-bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. De plus, nous expédions Aldolase B, Fructose-Bisphosphate Anticorps (93) et Aldolase B, Fructose-Bisphosphate Protéines (22) et beaucoup plus de produits pour cette protéine.
Showing 7 out of 20 products:
Silencing Aldolase B activated epithelial markers and repressed mesenchymal markers, indicating inactivation of Aldolase B may lead to inhibition of epithelial-mesenchymal transition
The downregulation of ALDOB could indicate a poor prognosis for HCC (Montrer FAM126A Kits ELISA) patients, and therefore, ALDOB might be considered a prognostic biomarker for HCC (Montrer FAM126A Kits ELISA), especially at the early stage.
ALDOC (Montrer ALDOC Kits ELISA), Aldolase (Montrer ALD Kits ELISA) A (ALDOA (Montrer ALDOA Kits ELISA)) and Aldolase B (ALDOB) activate Wnt (Montrer WNT2 Kits ELISA) signaling.
Single nucleotide polymorphisms in ALDOB, MAP3K1 (Montrer MAP3K1 Kits ELISA), and MEF2C (Montrer MEF2C Kits ELISA) are associated with cataract.
both of exogenous and endogenous ALDOB proteins bind to hepatitis B surface antigen and colocalize in the cytoplasm in vitro and inhibit apoptosis of cisplatin-induced HepG2 cells.
Efficient inhibition of aldolase B can prevent high glucose-induced overproduction of methylglyoxal and related cellular dysfunction in endothelial cells.
Aldolase B with the A149P substitution has activity that is <100-fold that of the wild type.
These novel mutations in ALDOB represent 2% of alleles in American HFI (Montrer MIP Kits ELISA) (hereditary fructose intolerance) patients, with IVS1+1G>C representing a significantly higher allele frequency (6%) among HFI (Montrer MIP Kits ELISA) patients of Hispanic and African-American ethnicity.
This is the first report of six unrelated patients sharing the same ALDOB deletion, thus indicating a founder effect for this allele.
Biochemical study of defective aldolase B enzymes is key to revealing the molecular basis of the disease and providing a stronger basis for improved treatment and diagnosis
characterization of the aldolase B gene enhancer
NKCC2 (Montrer SLC12A1 Kits ELISA) surface expression in mammalian cells is shown to be downregulated by a novel interaction with aldolase B
Fructose-1,6-bisphosphate aldolase (EC 188.8.131.52) is a tetrameric glycolytic enzyme that catalyzes the reversible conversion of fructose-1,6-bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. Vertebrates have 3 aldolase isozymes which are distinguished by their electrophoretic and catalytic properties. Differences indicate that aldolases A, B, and C are distinct proteins, the products of a family of related 'housekeeping' genes exhibiting developmentally regulated expression of the different isozymes. The developing embryo produces aldolase A, which is produced in even greater amounts in adult muscle where it can be as much as 5% of total cellular protein. In adult liver, kidney and intestine, aldolase A expression is repressed and aldolase B is produced. In brain and other nervous tissue, aldolase A and C are expressed about equally. There is a high degree of homology between aldolase A and C. Defects in ALDOB cause hereditary fructose intolerance.
aldolase B, fructose-bisphosphate
, Fructose-bisphosphate aldolase B
, fructose-bisphosphate aldolase B-like
, aldolase 2
, aldolase B, fructose-bisphosphatase
, fructose-bisphosphate aldolase B
, liver-type aldolase
, fructose 1,6, bisphosphate aldolase
, aldolase 2, B isoform
, Aldolase B fructose-biphosphate
, Aldolase B, fructose-biphosphate